Edwards Lifesciences Quick Ratio 2010-2024 | EW
Historical quick ratio values for Edwards Lifesciences (EW) over the last 10 years.
| Edwards Lifesciences Quick Ratio Historical Data | |||
|---|---|---|---|
| Date | Current Assets - Inventory | Current Liabilities | Quick Ratio |
| 2024-09-30 | $5.62B | $1.94B | 2.89 |
| 2024-06-30 | $3.49B | $1.22B | 2.87 |
| 2024-03-31 | $2.96B | $1.11B | 2.67 |
| 2023-12-31 | $3.13B | $1.20B | 2.62 |
| 2023-09-30 | $3.04B | $1.24B | 2.45 |
| 2023-06-30 | $2.67B | $1.16B | 2.31 |
| 2023-03-31 | $2.34B | $1.08B | 2.17 |
| 2022-12-31 | $2.22B | $1.02B | 2.17 |
| 2022-09-30 | $2.76B | $0.92B | 3.00 |
| 2022-06-30 | $2.52B | $0.97B | 2.60 |
| 2022-03-31 | $2.51B | $0.95B | 2.64 |
| 2021-12-31 | $2.45B | $1.03B | 2.38 |
| 2021-09-30 | $2.78B | $0.97B | 2.87 |
| 2021-06-30 | $2.56B | $0.89B | 2.89 |
| 2021-03-31 | $2.30B | $0.80B | 2.88 |
| 2020-12-31 | $2.29B | $0.89B | 2.56 |
| 2020-09-30 | $2.21B | $0.85B | 2.61 |
| 2020-06-30 | $1.96B | $0.87B | 2.24 |
| 2020-03-31 | $1.85B | $0.75B | 2.47 |
| 2019-12-31 | $2.34B | $0.90B | 2.60 |
| 2019-09-30 | $2.13B | $0.78B | 2.74 |
| 2019-06-30 | $1.73B | $0.70B | 2.48 |
| 2019-03-31 | $1.74B | $0.65B | 2.69 |
| 2018-12-31 | $1.68B | $0.88B | 1.92 |
| 2018-09-30 | $2.33B | $1.26B | 1.85 |
| 2018-06-30 | $2.13B | $1.45B | 1.47 |
| 2018-03-31 | $2.14B | $1.32B | 1.63 |
| 2017-12-31 | $1.99B | $1.42B | 1.40 |
| 2017-09-30 | $2.03B | $0.74B | 2.76 |
| 2017-06-30 | $1.79B | $0.56B | 3.19 |
| 2017-03-31 | $1.59B | $0.59B | 2.71 |
| 2016-12-31 | $1.84B | $0.53B | 3.46 |
| 2016-09-30 | $1.77B | $0.53B | 3.32 |
| 2016-06-30 | $1.62B | $0.48B | 3.38 |
| 2016-03-31 | $1.46B | $0.46B | 3.19 |
| 2015-12-31 | $1.71B | $0.48B | 3.59 |
| 2015-09-30 | $1.81B | $0.53B | 3.40 |
| 2015-06-30 | $1.98B | $0.45B | 4.46 |
| 2015-03-31 | $1.96B | $0.41B | 4.83 |
| 2014-12-31 | $1.93B | $0.43B | 4.54 |
| 2014-09-30 | $2.01B | $0.43B | 4.69 |
| 2014-06-30 | $1.96B | $0.54B | 3.63 |
| 2014-03-31 | $1.30B | $0.36B | 3.64 |
| 2013-12-31 | $1.42B | $0.35B | 4.10 |
| 2013-09-30 | $1.26B | $0.34B | 3.75 |
| 2013-06-30 | $1.09B | $0.31B | 3.47 |
| 2013-03-31 | $1.07B | $0.30B | 3.57 |
| 2012-12-31 | $1.01B | $0.35B | 2.91 |
| 2012-09-30 | $1.10B | $0.30B | 3.69 |
| 2012-06-30 | $1.01B | $0.28B | 3.57 |
| 2012-03-31 | $0.92B | $0.27B | 3.47 |
| 2011-12-31 | $0.91B | $0.34B | 2.71 |
| 2011-09-30 | $0.93B | $0.30B | 3.09 |
| 2011-06-30 | $0.99B | $0.31B | 3.15 |
| 2011-03-31 | $0.93B | $0.45B | 2.10 |
| 2010-12-31 | $0.83B | $0.34B | 2.45 |
| 2010-09-30 | $0.78B | $0.38B | 2.04 |
| 2010-06-30 | $0.74B | $0.25B | 2.97 |
| 2010-03-31 | $0.70B | $0.24B | 2.88 |
| 2009-12-31 | $0.72B | $0.29B | 2.49 |
| 2009-09-30 | $0.71B | $0.30B | 2.39 |
| 2009-06-30 | $0.59B | $0.25B | 2.39 |
| 2009-03-31 | $0.50B | $0.20B | 2.51 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $43.303B | $6.005B |
| Edwards Lifesciences Corporation deals in products and technologies aimed at treating advanced cardiovascular diseases, especially structural heart disease in critically ill patients. The company is the world's leading manufacturer of tissue heart valves and repair products used to replace or repair a patient's diseased or defective heart valve. Edwards is also a leading player in hemodynamic monitoring systems used to measure a patient's cardiovascular function in the hospital setting. The company's products and technologies are categorized into four main areas: Transcatheter Aortic Valve Replacement (TAVR), Transcatheter Mitral and Tricuspid Therapies (TMTT), Surgical Structural Heart, and Critical Care. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $207.434B | 25.31 |
| Intuitive Surgical (ISRG) | United States | $194.997B | 101.95 |
| Alcon (ALC) | Switzerland | $41.141B | 27.53 |
| IQVIA Holdings (IQV) | United States | $36.894B | 20.33 |
| IDEXX Laboratories (IDXX) | United States | $34.232B | 40.31 |
| DexCom (DXCM) | United States | $30.373B | 45.74 |
| Waters (WAT) | United States | $22.584B | 33.39 |
| STERIS (STE) | Ireland | $20.308B | 23.38 |
| SONOVA HOLDING (SONVY) | Switzerland | $19.662B | 0.00 |
| Hologic (HOLX) | United States | $16.272B | 17.57 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $13.198B | 13.55 |
| Globus Medical (GMED) | United States | $11.856B | 30.02 |
| Sysmex ADR (SSMXY) | Japan | $11.516B | 36.11 |
| Penumbra (PEN) | United States | $9.619B | 94.22 |
| Masimo (MASI) | United States | $8.910B | 43.11 |
| Glaukos (GKOS) | United States | $8.631B | 0.00 |
| Teleflex (TFX) | United States | $8.110B | 12.93 |
| Inari Medical (NARI) | United States | $4.642B | 0.00 |
| PROCEPT BioRobotics (PRCT) | United States | $4.532B | 0.00 |
| Integer Holdings (ITGR) | United States | $4.486B | 25.42 |
| Veracyte (VCYT) | United States | $3.219B | 96.60 |
| LivaNova (LIVN) | United Kingdom | $2.534B | 14.63 |
| Nihon Kohden (NHNKY) | Japan | $2.370B | 18.00 |
| Tandem Diabetes Care (TNDM) | United States | $2.364B | 0.00 |
| TransMedics (TMDX) | United States | $2.309B | 73.20 |
| Elekta AB (EKTAY) | Sweden | $2.138B | 19.22 |
| Integra LifeSciences Holdings (IART) | United States | $1.683B | 8.79 |
| Alphatec Holdings (ATEC) | United States | $1.414B | 0.00 |
| RxSight (RXST) | United States | $1.347B | 0.00 |
| Artivion (AORT) | United States | $1.253B | 83.00 |
| Pulse Biosciences (PLSE) | United States | $1.136B | 0.00 |
| OPKO Health (OPK) | United States | $1.003B | 0.00 |
| Paragon 28 (FNA) | United States | $0.867B | 0.00 |
| AxoGen (AXGN) | United States | $0.794B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.730B | 17.21 |
| IRadimed (IRMD) | United States | $0.717B | 38.76 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.699B | 11.88 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.650B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.592B | 0.00 |
| SiBone (SIBN) | United States | $0.575B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.575B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.498B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.476B | 25.05 |
| Treace Medical Concepts (TMCI) | United States | $0.455B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.413B | 22.38 |
| ClearPoint Neuro (CLPT) | United States | $0.405B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.367B | 0.00 |
| NeuroPace (NPCE) | United States | $0.356B | 0.00 |
| CVRx (CVRX) | United States | $0.344B | 0.00 |
| Inogen (INGN) | United States | $0.227B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.226B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.216B | 0.00 |
| Accuray (ARAY) | United States | $0.215B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.182B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.165B | 0.00 |
| Nevro (NVRO) | United States | $0.123B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.114B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.111B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.107B | 11.47 |
| LENSAR (LNSR) | United States | $0.096B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.086B | 0.00 |
| 908 Devices (MASS) | United States | $0.079B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.078B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.074B | 0.00 |
| InspireMD (NSPR) | Israel | $0.072B | 0.00 |
| Hyperfine (HYPR) | United States | $0.069B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.063B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.061B | 31.57 |
| Baird Medical Investment Holdings (BDMD) | $0.058B | 0.00 | |
| EnVVeno Medical (NVNO) | United States | $0.057B | 0.00 |
| Neuronetics (STIM) | United States | $0.052B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.050B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.044B | 0.00 |
| Spectral AI (MDAI) | United States | $0.041B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.039B | 0.00 |
| DarioHealth (DRIO) | United States | $0.031B | 0.00 |
| Precision Optics (POCI) | United States | $0.030B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.030B | 0.00 |
| Envoy Medical (COCH) | United States | $0.030B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.025B | 0.00 |
| NexGel (NXGL) | United States | $0.023B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.017B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.014B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.013B | 0.00 |
| Aspira Women's Health (AWH) | United States | $0.011B | 0.00 |
| QT Imaging Holdings (QTI) | United States | $0.010B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.009B | 0.00 |
| PAVmed (PAVM) | United States | $0.007B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.007B | 0.00 |
| Tenon Medical (TNON) | United States | $0.006B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.005B | 0.00 |
| Nuwellis (NUWE) | United States | $0.004B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.003B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |